Compugen Ltd Stock, NASDAQ:CGEN
Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858
Number of Employees: 68
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.